EY, Sensyne Health And Guardtime To Expand Health Outcomes Assessment Platform Using Blockchain And AI

Blockchain, Innovation, News | June 26, 2019 By:

Accounting services firm Ernst & Young (EY) is collaborating with with artificial intelligence (AI) firm Sensyne Health and blockchain company Guardtime to link healthcare reimbursement and actual patient outcomes.

The three companies will reportedly work together to expand the Health Outcomes Assessment platform, the first of its kind for the healthcare industry, to help provide an end-to-end solution for outcomes-based contracting – an approach that ties the payment of medicines to the achievement of specific clinical and patient satisfaction benchmarks and efficiency improvements in patient treatment pathways.

As part of the partnership, Sensyne Health will add clinical AI to evaluate patient health impact and Guardtime will add blockchain technologies to help enable the Health Outcomes Assessment platform to scale faster, which will lead to accurate and fair patient reimbursement. EY, on the other hand, will bring independent contract assessment, contract management and automated business process experience to allow pharmaceutical companies and health care providers to share data.

“We are delighted to be working to deliver the triple win: with life sciences companies increasing access to medicines, health care providers achieving greater efficiency and effectiveness and, most importantly, more patients getting better health outcomes,” said Dan Mathews, EY EMEIA Life Sciences Leader. “This is possible through the combination of novel technologies and a supporting commercial model that allows industry collaboration.”

Guardtime CEO Mike Gault said that the collaboration will enable payers, providers and pharma to move toward value-based healthcare.

“Guardtime’s KSI blockchain technology will help ensure patient-level data visibility without compromising data privacy, helping to ensure all participants can collaborate securely and with confidence,” Gault said. “We are excited about the opportunities this collaboration will bring to the health industry.”